RiverVest Venture Partners Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 11

Professionals

  • Investments
  • 152

  • Portfolio
  • 19

  • Exits
  • 49

Exits

RiverVest Venture Partners General Information

Company Description

Founded in 2000, RiverVest Venture Partners is a venture capital firm based in Saint Louis, Missouri. The firm seeks to invest in companies operating in the biopharma and medical device sectors.

Business Details

Year Founded
2000
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Corporate Office
  • 101 South Hanley Road
  • Suite 1850
  • Saint Louis, MO 63105
  • United States
+1 (314) 000-0000

RiverVest Venture Partners Investments (152)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Avalyn Pharma 22-Sep-2023 Later Stage VC 00000 Drug Discovery Clinical Trials - Phase 2
Maxwell Biomedical 02-Jun-2023 00000 00000 Therapeutic Devices Clinical Trials - Phase 1
OncoResponse 12-May-2023 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2 0000 0000000 00.0
InterVene 06-Mar-2023 00000 00000 000 Surgical Devices Generating Revenue 000 000000000
Spruce Biosciences 09-Feb-2023 0000 000.00 Biotechnology Clinical Trials - Phase 2 00000 0'0000000 00.0
Alleviant Medical 23-Jan-2023 00000 00000 0000 Therapeutic Devices Clinical Trials - General 000 000000000
Wugen 16-Dec-2022 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2 0000 0000000 00.0
Bonum Therapeutics 15-Nov-2022 00000 00000 0000 Drug Discovery Generating Revenue 0000 0000000 00.0
Biolinq 17-Oct-2022 Later Stage VC 00000 Monitoring Equipment Generating Revenue 00000 0000 00.0
Bluejay Therapeutics 16-Aug-2022 Early Stage VC 0000 Drug Discovery Pre-Clinical Trials 00000 0000 00.0
You’re viewing 10 of 152 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RiverVest Venture Partners Exits (49)

Company Name Exit Date Exit Type Exit Size
Scout Bio 25-Jan-2024 Buyout/LBO
Cardialen 14-Dec-2022 000000000000000000
Standard Bariatrics 27-Sep-2022 000000000000000000 00000
Good Therapeutics 18-Aug-2022 000000000000000000 00000
Neuros (Healthcare Technology Systems) 01-Aug-2022 000000000 00000000
Adarza BioSystems 01-May-2022 000 00 00000000
Smart Wires Technology 17-May-2021 000
Amplyx Pharmaceuticals 28-Apr-2021 000000000000000000
Reneo Pharmaceuticals 09-Apr-2021 IPO 000.00
Spruce Biosciences 09-Oct-2020 IPO 0000
You’re viewing 10 of 49 exits. Get the full list »

RiverVest Venture Partners Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore RiverVest Venture Partners‘s full profile, request access.

Request a free trial

RiverVest Venture Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

RiverVest Venture Partners Management, Team & Partners (33)

Name Title Deals Funds Boards Office
Sivan Weitzman Chief Financial Officer Saint Louis, MO
Jay Schmelter Co-Founder & Managing Director 00 00 0 Saint Louis, MO
Thomas Melzer Co-Founder & Managing Director 0 0 0 Saint Louis, MO
Derek Rapp Managing Director 0 0 0 Saint Louis, MO
Isaac Zike Ph.D Managing Director 0 Saint Louis, MO
You’re viewing 5 of 33 team members. Get the full list »

RiverVest Venture Partners Co-Investors (151)

Name With Exits Lead Partner Series Industry
503 Partners 5 0 0 Series chart Industry bar
Abingworth 0 0 Series chart Industry bar
American Century Investments 0 0 0 Series chart Industry bar
Novo Holdings 0 0 Series chart Industry bar
Rock Springs Capital 0 0 Series chart Industry bar
You’re viewing 5 of 151 co-investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »